Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation.

MLA

Clayton, Nicholas P., et al. “Sargramostim (Rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation.” Radiation Research, vol. 195, no. 2, Feb. 2021, pp. 191–99. EBSCOhost, https://doi.org/10.1667/RADE-20-00131.1.

APA

Clayton, N. P., Khan-Malek, R. C., Dangler, C. A., Zhang, D., Ascah, A., Gains, M., Gardner, B., Mockbee, C., Keutzer, J. M., McManus, J., & Authier, S. (2021). Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation. Radiation Research, 195(2), 191–199. https://doi.org/10.1667/RADE-20-00131.1

Chicago

Clayton, Nicholas P, Richard C Khan-Malek, Charles A Dangler, Donghui Zhang, Alexis Ascah, Malcolm Gains, Brent Gardner, et al. 2021. “Sargramostim (Rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation.” Radiation Research 195 (2): 191–99. doi:10.1667/RADE-20-00131.1.